AHA Center for Health Innovation Market Scan

AHA Center for Health Innovation’s Market Scan articles provide insights and analysis on the field’s latest developments in health care disruption, transformation and innovation.

Read the latest newsletters and subscribe to Market Scan.

Follow us to learn more.

Research about the Penn Medicine OnDemand telemedicine program for employees showed that virtual visits ended up being 23% less expensive to deliver than in-person appointments.
Professionals focused on improving community and population health and building partnerships, and those striving to advance diversity and inclusion within hospital management and executive levels recently convened at the third annual AHA Accelerating Health Equity Conference.
Seven organizations recently completed the third cohort of Verizon’s Forward for Good Accelerator, which is focused on scaling solutions that address barriers to health access and high-quality care.
Generative artificial intelligence (AI) has captured the attention of health care providers and payers focused on reimagining care delivery.
Retail health clinics are growing not only in number but in scope of services delivered. But so far, these outlets primarily are located in higher-income communities ringing urban areas with large populations while rural and underserved communities remain largely out of the picture.
The need for innovation in health care has never been greater. The AHA Leadership Summit July 16-18 in Seattle presents a unique opportunity to tap into insights from some of the top thought leaders and disrupters in health care.
America, and for that matter the world, is facing a growing challenge in caring for two expanding groups of patients — those 60 and older and patients with such chronic diseases as cancer, diabetes and obesity. We explore some technologies CB Insights analysts say providers should scrutinize over…
Amazon closed its Halo division, which sold fitness tracker devices that worked with a subscription service and smart phone application. CVS Health, meanwhile, recently announced that it will close its clinical trials division at the end of 2024.